Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LJ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,934 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Skyrizi 360 mg/2.4 ml on-body applicators. This non-set-aside delivery order is scheduled for completion by February 6, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 prime vendor agreement through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen's IDC with DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. As a leading pharmaceutical distributor, the company supplies critical medical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Skyrizi delivery order fulfills military medical procurement needs under this established contract vehicle, demonstrating the contractor's role as a primary pharmaceutical vendor for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9LJ8?
SPE2DR26F9LJ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LJ8 worth?
The government has obligated $24,934 on SPE2DR26F9LJ8.
Is contract SPE2DR26F9LJ8 an order under another contract?
Yes. SPE2DR26F9LJ8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LJ8 competed?
The extent of competition for SPE2DR26F9LJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award